CA ATC G03CA03 · updated 2 Nov 2026
Estradiol shortage in Canada
Is there an Estradiol shortage in Canada?
Yes. As of 2 Nov 2026, 7 Estradiol products are reported short in Canada, the first since 1 Jul 2019. The company estimate for the return is 6 Nov 2026 (latest 22 Jan 2027). Main reason: manufacturing problem.
Also short in Italy, Spain, Ireland, Belgium, Czechia, Norway, Sweden, Japan, New Zealand, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | ESTRACE (100) | ACERUS PHARMACEUTICALS CORPORATION | 1 Jul 2019 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ESTRACE (100) | ACERUS PHARMACEUTICALS CORPORATION | 1 Jul 2019 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ESTRACE (100) | ACERUS PHARMACEUTICALS CORPORATION | 1 Jul 2019 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | CLIMARA 50 (4's) | BAYER INC | 18 Sep 2026 | 15 Dec 2026 | Increased demand Demand increase for the drug |
| CA | ESTRADOT 37.5 (8TTS) | SANDOZ CANADA INCORPORATED | 13 Oct 2026 | 6 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ESTRADOT 75 (8TTS) | SANDOZ CANADA INCORPORATED | 13 Oct 2026 | 18 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ESTRADOT 25 (8TTS) anticipated | SANDOZ CANADA INCORPORATED | 30 Nov 2026 | 22 Jan 2027 | Distribution or logistics Delay in shipping of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.